BWX Technologies, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $BWXT in the last 30 days.
See all $BWXT insider activity →Antares has signed a fuel supply agreement with BWX Technologies (BWXT) to procure TRISO fuel for its microreactors until 2029. The deal includes an initial 1 metric ton of uranium, with options for more. BWXT will produce the fuel at its Virginia facility. Antares plans to use the fuel in its Mark-1 reactor, scheduled for 2027. This is Antares' second such agreement, following one with Standard Nuclear.
The U.S. Army allocated $2.2 billion to build nuclear microreactors for military installations, selecting BWX Technologies (NYSE: BWXT) as a vendor. BWXT, with experience in nuclear reactors for the U.S. Navy, could benefit from this contract. The stock has gained 136% over five years but declined 40% in the past six months.
BWX (BWXT) stock has dropped 40.6% in six months to $135.50. The company, a nuclear components and fuel provider, has shown strong revenue growth (10.7% CAGR over five years) and analysts project 14.3% revenue growth in the next 12 months. Its free cash flow margin expanded by 6.1 percentage points over five years, reaching 9% in the trailing 12 months. The stock trades at a forward P/E of 27.5x.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning BWXT (BWX Technologies, Inc.). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.
Recent BWXT coverage spans financial news, market movers and earnings.
The deal could boost BWXT's revenue from advanced nuclear fuel sales and support Antares' reactor deployments.
The contract is a large, first‑report award that could lift BWXT's valuation as investors price in new revenue.
The piece is a promotional analysis urging investors to consider BWXT as a value play after a steep decline.
BWX Technologies reported $601.8M revenue in FY 2025, up 38%, but a net loss of $198.2M. Rocket Lab aims to acquire Iridium Communications for $8B, expecting $1.4B revenue in 2027. BWX benefits from U.S. nuclear and military contracts, while Rocket Lab competes in space technology.
Guidance lift tied to commercial nuclear strength should support upward estimate revisions and near-term sentiment.
AlphAI scores every news story that mentions BWXT with an AI model for sentiment and relevance, and aggregates insider trades from BWX Technologies, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Antares has signed a fuel supply agreement with BWX Technologies (BWXT) to procure TRISO fuel for its microreactors until 2029. The deal includes an initial 1 metric ton of uranium, with options for more. BWXT will produce the fuel at its Virginia facility. Antares plans to use the fuel in its Mark-1 reactor, scheduled for 2027. This is Antares' second such agreement, following one with Standard Nuclear.
1 min readThe U.S. Army allocated $2.2 billion to build nuclear microreactors for military installations, selecting BWX Technologies (NYSE: BWXT) as a vendor. BWXT, with experience in nuclear reactors for the U.S. Navy, could benefit from this contract. The stock has gained 136% over five years but declined 40% in the past six months.
2 min readBWX (BWXT) stock has dropped 40.6% in six months to $135.50. The company, a nuclear components and fuel provider, has shown strong revenue growth (10.7% CAGR over five years) and analysts project 14.3% revenue growth in the next 12 months. Its free cash flow margin expanded by 6.1 percentage points over five years, reaching 9% in the trailing 12 months. The stock trades at a forward P/E of 27.5x.
2 min readBWX Technologies reported $601.8M revenue in FY 2025, up 38%, but a net loss of $198.2M. Rocket Lab aims to acquire Iridium Communications for $8B, expecting $1.4B revenue in 2027. BWX benefits from U.S. nuclear and military contracts, while Rocket Lab competes in space technology.
3 min readBWX Technologies (BWXT), Johnson & Johnson (JNJ), and UnitedHealth Group (UNH) raised FY26 guidance following strong quarterly results. BWXT reported 18% revenue growth and raised EPS guidance to $4.70–$4.80. JNJ saw 5.9% sales growth and increased EPS outlook to $11.10. UNH improved cost trends and raised EPS guidance to at least $20.50.
6 min readBWX Technologies (NYSE: BWXT) secured an $189 million contract to manufacture naval reactor fuel for the U.S. Navy, supporting various submarines and aircraft carriers. The company is the sole supplier of such fuel and components, with a strong backlog providing revenue visibility. This contract underscores BWXT's established role in nuclear energy, distinct from emerging small modular reactor developers.
2 min readBWX Technologies (BWXT) reported a 72% increase in commercial operations revenue in Q2 2026, with total revenue at $901.6M, up 18% YoY. The company secured a $4M design award from NNSA, reflecting its nuclear capabilities. BWXT's order backlog grew 40% YoY to $8.4B, with adjusted EPS at $1.07. Management aims to expand its nuclear focus beyond defense contracts.
2 min readBWX Technologies (BWXT) stock rose 7.7% after its BANR microreactor was selected for a project in Canada. Moody’s upgraded its outlook to positive. Analysts' views were mixed. The broader market also gained, with the S&P 500 up 0.9%.
1 min readBWX Technologies (BWXT) shares rose 8% after its BANR microreactor was selected for a nuclear power plant project in New Brunswick, Canada. The project, led by Prodigy Clean Energy and First Nations, aims to produce up to 50 MW of electricity by the early 2030s. BWXT will fabricate the reactor units at its Ontario facilities.
1 min readProdigy Clean Energy and two Indigenous groups selected BWX Technologies' (BWXT) Advanced Nuclear Reactor for a 50 MW transportable nuclear power plant in Belledune, New Brunswick, Canada. The project, planned for the early 2030s, will be Indigenous-owned and aims to validate logistics and operations for potential mass deployment.
1 min read
